These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 28395748

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Derivation of the human induced pluripotent stem cell line MUi017-A from a patient with homozygous Hemoglobin Constant Spring.
    Wongkummool W, Maneepitasut W, Munkongdee T, Tong-Ngam P, Tangprasittipap A, Svasti S, Kitiyanant N, Paiboonsukwong K, Fucharoen S, Tubsuwan A.
    Stem Cell Res; 2017 Apr; 20():84-87. PubMed ID: 28395746
    [Abstract] [Full Text] [Related]

  • 3. Generation and characterization of two iPSC lines from human epicardium-derived cells.
    Paulitschek C, Schulze-Matz P, Hesse J, Schmidt T, Wruck W, Adjaye J, Schrader J.
    Stem Cell Res; 2017 Apr; 20():50-53. PubMed ID: 28395740
    [Abstract] [Full Text] [Related]

  • 4. Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene.
    Liu S, Ye Z, Gao Y, He C, Williams DW, Moliterno A, Spivak J, Huang H, Cheng L.
    Stem Cell Res; 2017 Jan; 18():57-59. PubMed ID: 28395806
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Generation of induced pluripotent stem cells (iPSCs) stably expressing CRISPR-based synergistic activation mediator (SAM).
    Xiong K, Zhou Y, Hyttel P, Bolund L, Freude KK, Luo Y.
    Stem Cell Res; 2016 Nov; 17(3):665-669. PubMed ID: 27934604
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Generation and characterization of human iPSC line MML-6838-Cl2 from mobilized peripheral blood derived megakaryoblasts.
    Hansen M, Varga E, Wüst T, Brouwer N, Beauchemin H, Mellink C, van der Kevie-Kersemaekers AM, Möröy T, van der Reijden B, von Lindern M, van den Akker E.
    Stem Cell Res; 2017 Jan; 18():26-28. PubMed ID: 28395797
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Generation of induced pluripotent stem cell line from foreskin fibroblasts.
    Skrzypczyk A, Giri S, Bader A.
    Stem Cell Res; 2016 Nov; 17(3):572-575. PubMed ID: 27789413
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lymphoblast-derived integration-free ISRM-CON9 iPS cell line from a 75year old female.
    Martins S, Bohndorf M, Schröter F, Assar F, Wruck W, Sleegers K, Van Broeckhoven C, Adjaye J.
    Stem Cell Res; 2018 Jan; 26():76-79. PubMed ID: 29268155
    [Abstract] [Full Text] [Related]

  • 19. Generation of human iPSCs from urine derived cells of patient with a novel heterozygous PAI-1 mutation.
    Afzal MZ, Gartz M, Klyachko EA, Khan SS, Shah SJ, Gupta S, Shapiro AD, Vaughan DE, Strande JL.
    Stem Cell Res; 2017 Jan; 18():41-44. PubMed ID: 28395801
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.